Tocilizumab in COVID-19 therapy: who benefits, and how? - Authors' reply.

ABSTRACT:

SUBMITTER: Horby P 

PROVIDER: S-EPMC8298006 | biostudies-literature | 2021 Jul

REPOSITORIES: biostudies-literature